Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Medifast Q1 2024 Adj EPS $0.66 Misses $0.78 Estimate, Sales $174.739M Beat $168.900M Estimate

Author: Benzinga Newsdesk | April 29, 2024 04:31pm
Medifast (NYSE:MED) reported quarterly earnings of $0.66 per share which missed the analyst consensus estimate of $0.78 by 15.38 percent. This is a 82.02 percent decrease over earnings of $3.67 per share from the same period last year. The company reported quarterly sales of $174.739 million which beat the analyst consensus estimate of $168.900 million by 3.46 percent. This is a 49.93 percent decrease over sales of $348.983 million the same period last year.

Posted In: MED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist